DSM Nutritional Products and Monsanto announced this month that they have launched a strategic partnership to deliver the first stearidonate (SDA) omega-3 soybean oil for use in foods in North America.
Monsanto will develop SDA soybean varieties, sell SDA soybean seed to its farmer customers and license the trait to DSM, which will have the exclusive global rights to brand, market, package and sell the SDA soybean oil to the food industry.
SDA omega-3 soybean oil is a plant-based source of SDA, which naturally converts in the body to eicosapentaenoic acid omega-3, one of two main omega-3 fatty acids that has been clinically shown to promote heart health. The companies said this pipeline product will be the first vegetarian SDA derived from soybeans for use in food and beverage products in North America.
DSM said SDA soybean oil has a clean flavor, maintains shelf life, is stable and can be incorporated into a variety of foods, including dressings, sauces, margarines, spreads, bakery products, soups, snack bars and dairy-based products. SDA soybean oil could provide food and beverage manufacturers with an additional choice to access heart-healthy omega-3s and could represent an additional, sustainable omega-3 ingredient.
The Food & Drug Administration issued a positive to response to Monsanto's generally recognized as safe notification for the oil produced from SDA soybeans. Monsanto noted that it has completed key regulatory processes in the U.S., Canada and Mexico and has also made submissions for important approval in key export markets.